This is a competitive renewal application to continue to explore marine microorganisms as a new source for antitumor-antibiotics. The proposed project would continue as a collaboration between chemists and microbiologists at the Scripps Institution of Oceanography in La Jolla, CA. and cancer biologists at the Bristol-Myers Squibb Pharmaceutical Research Institute in Princeton, NJ. Studies proposed for the renewal period include the following: - The isolation, cultivation and biological evaluation of marine microorganisms from diverse habitats. The focus of the renewal application will be on 7 new groups of obligate marine actinomycetes (Salinospora, Marinomyces, and the MAR 3-7 groups) discovered during the past 24 months. - Overall, to continue to isolate and describe new molecules which show novel mechanisms of action in cancer-relevant, mechanism-based screens, show in vitro tissue type selectivity in the NCI 60 cell line and BMS ODCA panels, and to subsequently investigate their in vivo efficacies. - To focus a screening effort on the new cancer relevant targets IGF-1 Growth Factor, DMA Methyl Transferase-1 (DNMT-1), CoactivatorAssociated Arginine Methyltransferase (CARM-1) and Ceramidase, and on yeast selective DMA repair and cell checkpoint targets. These goals will also be supplemented at SIO with several assays which focus on infectious diseases (screening against drug resistant pathogens and for inhibitors of two selected bacterial efflux pumps). - To continue to advance previous discoveries (Salinosporamide A, Halimide, Sargassamide A and several other molecules) for in vivo evaluation in the BMS P388 and L1210 leukemias and the murine solid tumor models M109, Mam16/C and M50766.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Method to Extend Research in Time (MERIT) Award (R37)
Project #
Application #
Study Section
Special Emphasis Panel (NSS)
Program Officer
Fu, Yali
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Diego
Schools of Earth Sciences/Natur
La Jolla
United States
Zip Code
Yim, Chae-Yoon; Le, Tu Cam; Lee, Tae Gu et al. (2017) Saccharomonopyrones A-C, New ?-Pyrones from a Marine Sediment-Derived Bacterium Saccharomonospora sp. CNQ-490. Mar Drugs 15:
Beuzer, Paolo; Axelrod, Joshua; Trzoss, Lynnie et al. (2016) Single dish gradient screening of small molecule localization. Org Biomol Chem 14:8241-5
Le, Tu Cam; Yang, Inho; Yoon, Yeo Joon et al. (2016) Ansalactams B-D Illustrate Further Biosynthetic Plasticity within the Ansamycin Pathway. Org Lett 18:2256-9
Leutou, Alain S; Yang, Inho; Kang, Heonjoong et al. (2015) Nocarimidazoles A and B from a Marine-Derived Actinomycete of the Genus Nocardiopsis. J Nat Prod 78:2846-9
Nam, Sang-Jip; Kauffman, Christopher A; Jensen, Paul R et al. (2015) Actinobenzoquinoline and Actinophenanthrolines A-C, Unprecedented Alkaloids from a Marine Actinobacterium. Org Lett 17:3240-3
Choi, Eun Ju; Nam, Sang-Jip; Paul, Lauren et al. (2015) Previously Uncultured Marine Bacteria Linked to Novel Alkaloid Production. Chem Biol 22:1270-9
Álvarez-Micó, Xavier; Rocha, Danilo D; Guimarães, Larissa A et al. (2015) The Hybrid Pyrroloisoindolone-Dehydropyrrolizine Alkaloid (-)-Chlorizidine?A Targets Proteins within the Glycolytic Pathway. Chembiochem 16:2002-6
Jensen, Paul R; Moore, Bradley S; Fenical, William (2015) The marine actinomycete genus Salinispora: a model organism for secondary metabolite discovery. Nat Prod Rep 32:738-51
Jensen, Paul R; Chavarria, Krystle L; Fenical, William et al. (2014) Challenges and triumphs to genomics-based natural product discovery. J Ind Microbiol Biotechnol 41:203-9
Farnaes, Lauge; Coufal, Nicole G; Kauffman, Christopher A et al. (2014) Napyradiomycin derivatives, produced by a marine-derived actinomycete, illustrate cytotoxicity by induction of apoptosis. J Nat Prod 77:15-21

Showing the most recent 10 out of 91 publications